Clinical trial
Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms
NCT00475241 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00475241 |
|---|---|
| Title | Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms |
| Official title | Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Combat Disorders, Posttraumatic Stress Disorder |
| Intervention type | Behavioral |
| Interventions | Prolonged Exposure therapy for PTSD, Present centered therapy for PTSD |
| Enrollment | 36 |
| Start date | Jan 1, 2008 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | May 21, 2007 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: